<ul>
<li>Prologis 股票飆升：為何這一漲勢可能會持續</li>
</ul>
<p>根據 MarketBeat 的股票篩選工具，Prologis、Ascendis Pharma A/S 和 Teledyne Technologies 是今天值得關注的三隻成長股。成長股是指預計收入和收益增長速度快於整體市場的公司的股票。它們通常將利潤再投資於擴張，而不是支付股息，通常以更高的估值倍數交易，並吸引尋求資本增值的投資者，儘管波動性較高。這些公司在過去幾天內的成長股中交易量最高。</p>
<h2>Prologis (PLD)</h2>
<p>Prologis, Inc.是全球物流房地產的領導者，專注於高壁壘、高增長市場。截至 2024 年 3 月 31 日，該公司在 19 個國家擁有或投資的物業和開發項目預計總面積約為 12 億平方英尺（1.15 億平方米）。</p>
<ul>
<li>3 只在市場波動中應持有的股息股票</li>
</ul>
<p>閲讀我們關於 PLD 的最新研究報告</p>
<h2>Ascendis Pharma A/S (ASND)</h2>
<p>Ascendis Pharma A/S 是一家生物製藥公司，專注於開發滿足未滿足醫療需求的療法。它提供 SKYTROFA 用於治療生長激素缺乏症（GHD）患者。該公司還在臨牀開發中開發三種獨立內分泌罕見疾病產品候選藥物，並專注於推進腫瘤治療候選藥物。</p>
<ul>
<li>3 只推動 AI 基礎設施繁榮的雲計算建設股票</li>
</ul>
<p>閲讀我們關於 ASND 的最新研究報告</p>
<h2>Teledyne Technologies (TDY)</h2>
<p>Teledyne Technologies Incorporated 及其子公司為美國及國際工業增長市場提供支持技術。其數字成像部門提供可見光譜傳感器和數字相機；以及紅外、紫外、可見光和 X 射線光譜；以及微機電系統和半導體，包括模數轉換器和數模轉換器。</p>
<p>閲讀我們關於 TDY 的最新研究報告</p>
<h2>另見</h2>
<ul>
<li>MarketBeat 在 2025 年 12 月的五大股票推薦</li>
<li>微軟落後於市場——但其護城河在 2026 年可能更重要</li>
<li>Kroger 催化劑：20 億美元的購買理由</li>
<li>華爾街為何放棄輝瑞——這可能是個錯誤</li>
<li>黃金、白銀和銅價格飆升——這裏有 3 種聰明的投資方式</li>
<li>在收益前的 4 周內，亞馬遜會有什麼表現</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Prologis 嗎？</h2>
<p>在考慮 Prologis 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Prologis 並不在名單上。</p>
<p>雖然 Prologis 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

Ascendis制藥

安博

<p>根據 MarketBeat 的報道，Prologis、Ascendis Pharma A/S 和 Teledyne Technologies 被強調為今天值得關注的成長股。成長股預計將超越市場的收入和盈利增長，通常會將利潤再投資用於擴張。Prologis 在物流房地產領域處於領先地位，Ascendis 專注於生物製藥，而 Teledyne 為工業市場提供技術。這些公司最近顯示出高交易量，吸引了尋求資本增值的投資者，儘管市場波動性較大</p>

<ul>
<li>Prologis Stock Surges: Why the Rally May Continue</li>
</ul>
<div class="lb-trans"><ul>
<li>Prologis 股票飆升：為何這一漲勢可能會持續</li>
</ul>
</div><p>Prologis, Ascendis Pharma A/S, and Teledyne Technologies are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow revenues and earnings faster than the overall market. They typically reinvest profits into expansion rather than paying dividends, often trade at higher valuation multiples, and appeal to investors seeking capital appreciation despite higher volatility. These companies had the highest dollar trading volume of any Growth stocks within the last several days.</p>
<div class="lb-trans"><p>根據 MarketBeat 的股票篩選工具，Prologis、Ascendis Pharma A/S 和 Teledyne Technologies 是今天值得關注的三隻成長股。成長股是指預計收入和收益增長速度快於整體市場的公司的股票。它們通常將利潤再投資於擴張，而不是支付股息，通常以更高的估值倍數交易，並吸引尋求資本增值的投資者，儘管波動性較高。這些公司在過去幾天內的成長股中交易量最高。</p>
</div><h2>Prologis (PLD)</h2>
<div class="lb-trans"><h2>Prologis (PLD)</h2>
</div><p>Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.</p>
<div class="lb-trans"><p>Prologis, Inc.是全球物流房地產的領導者，專注於高壁壘、高增長市場。截至 2024 年 3 月 31 日，該公司在 19 個國家擁有或投資的物業和開發項目預計總面積約為 12 億平方英尺（1.15 億平方米）。</p>
</div><ul>
<li>3 Dividend Stocks to Hold Through Market Volatility This Fall</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只在市場波動中應持有的股息股票</li>
</ul>
</div><p>Read Our Latest Research Report on PLD</p>
<div class="lb-trans"><p>閲讀我們關於 PLD 的最新研究報告</p>
</div><h2>Ascendis Pharma A/S (ASND)</h2>
<div class="lb-trans"><h2>Ascendis Pharma A/S (ASND)</h2>
</div><p>Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.</p>
<div class="lb-trans"><p>Ascendis Pharma A/S 是一家生物製藥公司，專注於開發滿足未滿足醫療需求的療法。它提供 SKYTROFA 用於治療生長激素缺乏症（GHD）患者。該公司還在臨牀開發中開發三種獨立內分泌罕見疾病產品候選藥物，並專注於推進腫瘤治療候選藥物。</p>
</div><ul>
<li>3 Cloud Build-Out Stocks Behind the AI Infrastructure Boom</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只推動 AI 基礎設施繁榮的雲計算建設股票</li>
</ul>
</div><p>Read Our Latest Research Report on ASND</p>
<div class="lb-trans"><p>閲讀我們關於 ASND 的最新研究報告</p>
</div><h2>Teledyne Technologies (TDY)</h2>
<div class="lb-trans"><h2>Teledyne Technologies (TDY)</h2>
</div><p>Teledyne Technologies Incorporated, together with its subsidiaries, provides enabling technologies for industrial growth markets in the United States and internationally. Its Digital Imaging segment provides visible spectrum sensors and digital cameras; and infrared, ultraviolet, visible, and X-ray spectra; as well as micro electromechanical systems and semiconductors, including analog-to-digital and digital-to-analog converters.</p>
<div class="lb-trans"><p>Teledyne Technologies Incorporated 及其子公司為美國及國際工業增長市場提供支持技術。其數字成像部門提供可見光譜傳感器和數字相機；以及紅外、紫外、可見光和 X 射線光譜；以及微機電系統和半導體，包括模數轉換器和數模轉換器。</p>
</div><p>Read Our Latest Research Report on TDY</p>
<div class="lb-trans"><p>閲讀我們關於 TDY 的最新研究報告</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>MarketBeat's Top Five Stocks to Own in December 2025</li>
<li>Microsoft Is Lagging the Market—But Its Moat May Matter More in 2026</li>
<li>The Kroger Catalyst: $2 Billion Reasons to Buy</li>
<li>Why Wall Street Gave Up on Pfizer—and Why That May Be a Mistake</li>
<li>Gold, Silver, and Copper Are Surging—Here Are 3 Smart Ways to Play It</li>
<li>What to Expect From Amazon in the 4 Weeks Before Earnings</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 在 2025 年 12 月的五大股票推薦</li>
<li>微軟落後於市場——但其護城河在 2026 年可能更重要</li>
<li>Kroger 催化劑：20 億美元的購買理由</li>
<li>華爾街為何放棄輝瑞——這可能是個錯誤</li>
<li>黃金、白銀和銅價格飆升——這裏有 3 種聰明的投資方式</li>
<li>在收益前的 4 周內，亞馬遜會有什麼表現</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Prologis Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Prologis 嗎？</h2>
</div><p>Before you consider Prologis, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Prologis 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Prologis wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Prologis 並不在名單上。</p>
</div><p>While Prologis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Prologis 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

12 月 31 日值得關注的成長型股票